[e-drug] HIV and drug interactions

[Kirsten Myhr <kirsten.myhr@relis.ulleval.no>]

E-drug: HIV and drug interactions
------------------------------------------------------------


HIV/AIDS patients take many medicines (if they have access to or 
can afford them) and it is important to assess the risk of adverse 
effects as well as drug interactions. Scrip no 2693, 7 November has 
a note about a special website for HIV drug interactions. It is 
maintained by the Liverpool University's HIV pharmacology group 
(LHPG) and can be found at www.hiv-druginteractions.org. It also 
covers the latest advances in the use of therapeutic drug monitoring 
to improve the clinical management of HIV-positive patients.

The following article can be of interest in assessing the risk of 
adverse events of treatment:
Fellay J et al. Prevalence of adverse events associated with potent
antiretroviral treatment: Swiss HIV Cohort Study. Lancet 2001; 358:
1322-27 (20 October)

Kirsten

Kirsten Myhr, MScPharm, MPH
Head of Eastern Region Drug Information Centre

RELIS Ost
Ulleval University Hospital
N-0407 OSLO
Tel: +47 23 01 64 11  Fax: +47 23 01 64 10
kirsten.myhr@relis.ulleval.no (w)
myhr@online.no (h)
www.relis.no

--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: owner-e-drug@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html